Johnson & Johnson (NYSE:JNJ) (NYSE: JNJ) is a global healthcare company that develops, manufactures and markets pharmaceutical and medical device products. Founded in 1886 and headquartered in New Brunswick, New Jersey, the company serves patients, healthcare professionals and institutions in markets around the world.
Johnson & Johnson operates through two primary business segments: Innovative Medicine and MedTech. Innovative Medicine focuses on prescription treatments in areas including immunology, oncology, neuroscience, cardiovascular and metabolic disease, infectious diseases, and pulmonary hypertension. Its portfolio includes medicines marketed under brands such as Stelara, Darzalex, Erleada and Tremfya.
The MedTech segment provides products and technologies used in surgery, orthopaedics, cardiovascular care, and vision care. Its offerings include surgical instruments and systems, orthopaedic implants, electrophysiology and other cardiovascular technologies, and contact lenses. Johnson & Johnson completed the separation of its consumer health business, now known as Kenvue, in 2023.
Joaquin Duato has served as Johnson & Johnson’s chief executive officer since January 2022 and became chairman of the board in 2022. The company’s history traces back to the development of sterile surgical products by brothers Robert Wood Johnson, James Wood Johnson and Edward Mead Johnson.
